The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis

BACKGROUND: A common complication of viral pulmonary infections, such as in the ongoing COVID-19 pandemic, is a phenomenon described as a “cytokine storm”. While poorly defined, this hyperinflammatory response results in diffuse alveolar damage. The low molecular weight fraction of commercial human...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Gregory, Frederick, Elizabeth, Hausburg, Melissa, Goldberg, Laura, Hoke, Marshall, Roshon, Michael, Mains, Charles, Bar-Or, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220573/
https://www.ncbi.nlm.nih.gov/pubmed/32431755
http://dx.doi.org/10.1186/s13037-020-00248-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220573/
https://www.ncbi.nlm.nih.gov/pubmed/32431755
http://dx.doi.org/10.1186/s13037-020-00248-4

Ejemplares similares